David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
PUT
Air Products & Chemicals
APD
$67.7B
| $5.8M | ﹤0.01% |
20,000
| – | – |
|
1727
CALL
Jefferies Financial Group
JEF
$12.1B
| $5.79M | ﹤0.01% |
73,800
-16,700
| -18% | -$1.2M |
|
1728
CALL
STMicroelectronics
STM
$44.1B
| $5.79M | ﹤0.01% |
231,700
+156,700
| +209% | +$4.16M |
|
1729
PUT
FMC
FMC
$1.4B
| $5.78M | ﹤0.01% |
119,000
-40,000
| -25% | -$2.34M |
|
1730
CALL
Altria Group
MO
$114B
| $5.76M | ﹤0.01% |
110,200
-280,000
| -72% | -$14.9M |
|
1731
Pennant Group
PNTG
$1.34B
| $5.75M | ﹤0.01% |
216,854
-76,381
| -26% | -$2.41M |
|
|
ILPT
1732
Industrial Logistics Properties Trust
ILPT
$562M
| $5.75M | ﹤0.01% |
1,574,742
+19,995
| +1% | +$77.1K |
|
1733
CALL
Intuitive Surgical
ISRG
$131B
| $5.74M | ﹤0.01% |
11,000
-31,600
| -74% | -$16.5M |
|
|
1734
PUT
Intuitive Surgical
ISRG
$131B
| $5.74M | ﹤0.01% |
11,000
| – | – |
|
1735
CALL
Akamai
AKAM
$15.2B
| $5.74M | ﹤0.01% |
60,000
+14,300
| +31% | +$1.4M |
|
1736
PUT
AB InBev
BUD
$155B
| $5.73M | ﹤0.01% |
+114,400
| New | +$6.62M |
|
|
TMHC
1737
DELISTED
Taylor Morrison
TMHC
| $5.73M | ﹤0.01% |
93,560
+85,926
| +1,126% | +$5.86M |
|
1738
IMAX
IMAX
$2.96B
| $5.72M | ﹤0.01% |
223,630
+54,977
| +33% | +$1.29M |
|
1739
Vishay Intertechnology
VSH
$4.8B
| $5.72M | ﹤0.01% |
337,882
-909,705
| -73% | -$16M |
|
1740
Heron Therapeutics
HRTX
$61.3M
| $5.7M | ﹤0.01% |
3,723,706
-660,971
| -15% | -$1.07M |
|
1741
BWX Technologies
BWXT
$13.7B
| $5.67M | ﹤0.01% |
50,871
-33,587
| -40% | -$4.1M |
|
1742
PUT
Papa John's
PZZA
$794M
| $5.66M | ﹤0.01% |
137,800
+3,700
| +3% | +$182K |
|
1743
US Foods
USFD
$23.6B
| $5.66M | ﹤0.01% |
83,877
-62,731
| -43% | -$4.12M |
|
1744
Federated Hermes
FHI
$4.88B
| $5.65M | ﹤0.01% |
137,527
-197,999
| -59% | -$8M |
|
1745
Upland Software
UPLD
$13.9M
| $5.65M | ﹤0.01% |
130,106
+15,467
| +13% | +$502K |
|
1746
Comstock Resources
CRK
$4.16B
| $5.64M | ﹤0.01% |
309,751
+290,075
| +1,474% | +$4.02M |
|
1747
CALL
Macerich
MAC
$6.88B
| $5.64M | ﹤0.01% |
283,000
| – | – |
|
1748
CALL
Synopsys
SNPS
$78.3B
| $5.63M | ﹤0.01% |
11,600
-4,800
| -29% | -$2.51M |
|
1749
CALL
Thermo Fisher Scientific
TMO
$232B
| $5.62M | ﹤0.01% |
10,800
-3,000
| -22% | -$1.65M |
|
1750
PUT
Williams-Sonoma
WSM
$27.6B
| $5.61M | ﹤0.01% |
30,300
+5,900
| +24% | +$936K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.